|
Home : Unsafe Drugs : Avandia : News Articles : 2010: Pharma's year in review | InPharm 2010: Pharma's year in review | InPharm
In September GSK's diabetes drug Avandia was withdrawn from the market in Europe because of high levels of heart attack, heart failure and stroke in patients. In the US, the FDA took a contrasting approach, by stopping short of a complete withdrawal of the ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




